# NAD Supplementation and Vascular Health in PAD

> **NCT06534944** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 8 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DRUG:** Nicotinamide riboside

## Key facts

- **NCT ID:** NCT06534944
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06534944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06534944, "NAD Supplementation and Vascular Health in PAD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06534944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*